Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071565 · ClinicalTrials.gov registry record
Familial Intracranial Aneurysm Study II
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 5,875
- Enrollment target
NCT00071565: Completed study, sponsored by University of Cincinnati.
NCT00071565 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 5,875 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00071565 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 5,875 participants
- Enrollment target
Study Summary
The purposes of this study are to identify possible genes that may increase the risk of aneurysm development in the brain, and to determine the effect of environmental factors such as cigarette smoking and high blood pressure on the expression of these genes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,875 participants |
| Start Date | 2002-09 |
| Est. Completion | 2015-05 |
What the finished NCT00071565 record still lists
NCT00071565 is an observational study that tracks outcomes without assigning an intervention. Its 5,875 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00071565 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00071565 about?
NCT00071565 is a clinical study titled "Familial Intracranial Aneurysm Study II". The purposes of this study are to identify possible genes that may increase the risk of aneurysm development in the brain, and to determine the effect of environmental factors such as cigarette smoking and high blood pressure on the expression of these genes.
What is the current status of trial NCT00071565?
This trial is currently completed. The enrollment target is 5,875 participants. The study started on 2002-09. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT00071565?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03959085 · 5,951 participants · Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- NCT06192511 · 5,980 participants · NA
Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia